Ellen
1.19 SEK +2.59%Be the first to follow this company
Ellen specializes in biotechnology. The company focuses on products for women's health. Ellen develops and sells sanitary protection for women based on probiotics (lactic acid bacteria). The products are sold under separate brands. The largest operations are held in the Nordic and European markets, where sales take place via licensed distributors. The company was established in 2000 and is headquartered in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ELN
Daily low / high price
1.19 / 1.19
SEK
Market cap
13.18M SEK
Turnover
3.57 SEK
Volume
3
Financial calendar
Interim report
2024-08-30
Annual report
2025-02-28
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Lövgren & Partners AB | 21.7 % | 21.7 % |
Sven Mattson | 15.9 % | 15.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Kommuniké från årsstämma i Ellen AB (publ)
Komplettering: Ellen AB publicerar Årsredovisning för 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools